148 related articles for article (PubMed ID: 38800340)
1. A Randomized Controlled Trial Comparing Efficacy and Safety of Antidepressant Monotherapy.
Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
Cureus; 2024 Apr; 16(4):e59074. PubMed ID: 38800340
[TBL] [Abstract][Full Text] [Related]
2. An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder.
Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
Cureus; 2023 Apr; 15(4):e37858. PubMed ID: 37213947
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Hamilton Depression Rating Scale and Montgomery-Åsberg Depression Rating Scale: Baked Straight From a Randomized Study.
Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
Cureus; 2023 Sep; 15(9):e45098. PubMed ID: 37842359
[TBL] [Abstract][Full Text] [Related]
4. A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder.
Sinha S; Chary S; Thakur P; Talluri L; Reddy M; Verma KK; Saha P; Gupta VB; Ramaiah KA; Khanum SZ
Cureus; 2021 Jul; 13(7):e16689. PubMed ID: 34513348
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study.
Kadam RL; Sontakke SD; Tiple P; Motghare VM; Bajait CS; Kalikar MV
Indian J Pharmacol; 2020; 52(2):79-85. PubMed ID: 32565594
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Effects of Antidepressants: Results of a Randomized Study's Interim Analysis.
Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
Cureus; 2023 Jul; 15(7):e42585. PubMed ID: 37641760
[TBL] [Abstract][Full Text] [Related]
8. An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder.
Rele S; Millet R; Kim S; Paik JW; Kim S; Masand PS; Patkar AA
Prim Care Companion CNS Disord; 2015; 17(4):. PubMed ID: 26693034
[TBL] [Abstract][Full Text] [Related]
9. Vortioxetine for depression in adults.
Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder.
Khan A; Cutler AJ; Kajdasz DK; Gallipoli S; Athanasiou M; Robinson DS; Whalen H; Reed CR
J Clin Psychiatry; 2011 Apr; 72(4):441-7. PubMed ID: 21527122
[TBL] [Abstract][Full Text] [Related]
11. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
12. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Rickels K; Athanasiou M; Robinson DS; Gibertini M; Whalen H; Reed CR
J Clin Psychiatry; 2009 Mar; 70(3):326-33. PubMed ID: 19284933
[TBL] [Abstract][Full Text] [Related]
13. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L
J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
[TBL] [Abstract][Full Text] [Related]
15. Quality of Life and Medication Adherence in Patients With Major Depressive Disorder: An Interim Analysis of a Randomized Study.
Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
Cureus; 2023 Jun; 15(6):e39997. PubMed ID: 37415997
[TBL] [Abstract][Full Text] [Related]
16. The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.
Reed CR; Kajdasz DK; Whalen H; Athanasiou MC; Gallipoli S; Thase ME
Curr Med Res Opin; 2012 Jan; 28(1):27-39. PubMed ID: 22106941
[TBL] [Abstract][Full Text] [Related]
17. Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study.
Lee SH; Jeon SW; Shin C; Pae CU; Patkar AA; Masand PS; An H; Han C
Psychiatry Investig; 2022 Apr; 19(4):268-280. PubMed ID: 35500900
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder.
Jacobsen PL; Mahableshwarkar AR; Serenko M; Chan S; Trivedi MH
J Clin Psychiatry; 2015 May; 76(5):575-82. PubMed ID: 26035185
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms.
Baldwin DS; Florea I; Jacobsen PL; Zhong W; Nomikos GG
J Affect Disord; 2016 Dec; 206():140-150. PubMed ID: 27474960
[TBL] [Abstract][Full Text] [Related]
20. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
